‘Healthy Aging and Longevity Forum’ to take place at HKBIO2023 International Convention

Christine Huang Yuan, Founder and Managing Director of HK Longevity Medical Center, joins us to explain why longevity and healthy aging is top of the agenda at the forthcoming HKBIO convention.

The HKBIO2023 International Convention, a prestigious event bringing together leading experts, researchers, and industry professionals in the biotechnology and healthcare sectors, is pleased to announce the inclusion of the first highly anticipated Healthy Aging and Longevity Forum. Taking place on 13 September 2023, the forum will serve as a platform for renowned experts to share insights, exchange ideas, and discuss cutting-edge advancements in the field. The forum will encompass a wide range of topics, including medical interventions, lifestyle modifications, technological innovations, and policy initiatives aimed at promoting healthy aging and extending the human lifespan.

The forum will feature a strong lineup of distinguished speakers who are recognized for their contributions to the field of aging and longevity research. The keynote speaker for the forum, Professor Bruce Beutler, is a globally recognized figure in the fields of immunology and aging. As the recipient of the 2011 Nobel Prize in Physiology or Medicine, Professor Beutler’s groundbreaking work on innate immunity has revolutionized our understanding of aging and disease. His speech Automated meiotic mapping for the discovery of protective mutations for disease resistance to cancer and the frailty of aging will undoubtedly provide invaluable insights into the mechanisms underlying healthy aging and longevity.

Professor Bruce Beutler

In addition to Professor Beutler’s keynote address, the Healthy Aging and Longevity Forum will present a notable lineup of longevity experts from Asia. Professor Hidekazu Yamada, President of the Japanese Society of Anti-Aging Medicine (JAAM), leads the mission to develop reliable, universally accepted tools for quantifying biological age. The goal of this endeavor is to propose the inclusion of these biomarkers in the International Classification of Diseases (ICD-12) by 2050. This would provide a system to classify an individual’s biological age, marking a significant stride to the field of aging and longevity.

Professor Hidekazu Yamada (left) and Professor Zhongjun Zhou (right)

We’re also pleased to welcome Professor Zhongjun Zhou, the co-founding Chair of the Asian Association of Aging Research and Chief Editor of the scientific journal Translational Medicine of Aging. Known for his groundbreaking work in aging, particularly his identification of Lamin A’s role in Hutchinson-Gilford Progeria Syndrome (HGPS), Professor Zhou has fundamentally redefined our understanding of aging, establishing a tangible link between genomic instability and the aging process. He will share his research findings and approaches to tackling age-associated diseases.

These experts, along with others from various disciplines across Asia, Middle East, Europe, etc, will present their findings and innovative methods for quantifying and promoting healthy aging. Attendees can look forward to interactive sessions, thought-provoking discussions and an unparalleled opportunity to gain wisdom from these esteemed practitioners in the field.

“As one of the World’s top financial centers, Hong Kong utilized the power of biotechnology to resist pandemic-induced economic decline and significant demographic shifts are spurring Hong Kong’s emergence as a new player in innovative healthcare,” says Professor Albert Cheung-hoi YU, PhD, JP, President of BIOHK2023.

'Healthy Aging and Longevity Forum' to take place at HKBIO2023 International Convention
Professor Albert Cheung-hoi YU

“As a city with a rich history in industrial development and innovation, and one that is frequently coined as ‘Asia’s World City’, there is no better place to bring together biotech companies from both East and West other than here at the BIOHK2023 International Convention. I am wholeheartedly glad to have the first ‘Healthy Aging and Longevity Forum’ at HKBIO2023 and believe it will play a pivotal role in addressing the challenges and opportunities associated with healthy aging. This forum provides an exceptional opportunity for experts from diverse backgrounds to come together, share their knowledge, and collectively work towards improving the health and well-being of aging populations worldwide.”

I wholeheartedly agree; we are thrilled to host the Healthy Aging and Longevity Forum as part of the HKBIO2023 International Convention – this forum will provide a unique platform for experts across various disciplines to come together, share insights, and explore strategies to address the challenges and opportunities associated with healthy aging. We believe that by fostering collaboration and knowledge exchange, we can make significant progress in promoting long and fulfilling lives for individuals around the world.

The HKBIO2023 International Convention will take place at the Hong Kong Exhibition Centre from September 13 to 16, 2023, showcasing the latest advancements in biotechnology, healthcare products, and medical research. In addition to the “Healthy Aging and Longevity Forum,” the event will feature a comprehensive program consisting of keynote speeches, panel discussions, interactive workshops, and an exhibition hall where participants can explore the latest innovations and network with industry professionals.

Registration for the “Healthy Aging and Longevity Forum” and the HKBIO2023 International Convention is now open. Interested individuals are encouraged to visit the official event website HERE for more information and to secure their spot at this highly anticipated gathering.

About Christine Huang Yuan

'Healthy Aging and Longevity Forum' to take place at HKBIO2023 International Convention

Dr Christine Huang Yuan is the Technology Transfer Director of Hong Kong Quantum AI Lab, Founder and Managing Director of HK Longevity Medical Center, the first and only AI-driven longevity clinic in Hong Kong; she is a Venture Partner of LongeVC and a Senior Research Associate at the University of Hong Kong. Huang was selected as one of Forbes China 2020 30 Under 30 (Healthcare and Science), and is a Fellow of the Royal Society of Medicine in the UK. She is also a member of the Advisory Board of Wing Wah Charity Foundation Hong Kong, and a columnist for Forbes China. Huang was elected as a Fellow of Guangzhou Youth Federation in November 2022.

Dr Huang graduated from Southern Medical University with Doctor of Medicine, and obtained a Master’s degree from the Li Ka Shing Faculty of Medicine of the University of Hong Kong the Li Ka Shing Faculty of Medicine of the University of Hong Kong and later on trained in the neurology department of Queen Mary Hospital in Hong Kong, where she participated in several large-scale international clinical trials. She is skilled in translational medicine, especially in the fields of AI-driven medicine, age-associated diseases (neurodegenerative diseases, cancer, diabetes, &c) and longevity medicine.